Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)

Rachel Galot, Christophe Le Tourneau, Lisa Licitra, Joël Guigay, Anthony Kong, Ingeborg Tinhofer, Caroline Even, Amaury Daste, Esma Saada-Bouzid, Frédéric Rolland, Stéphanie Henry, Sylvie Rottey, Emmanuel Seront, Annemie Rutten, Athénais van der Elst, Konstantina Tsechilidou, Lieve Dirix, Catherine Fortpied, Ana Joaquim, Anne-Sophie Govaerts, Jean-Pascal Machiels

Open source

DOI: 10.1016/j.ejca.2026.117791
Published: 2026-12
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.117791,
  title = {Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)},
  author = {Rachel Galot and Christophe Le Tourneau and Lisa Licitra and Joël Guigay and Anthony Kong and Ingeborg Tinhofer and Caroline Even and Amaury Daste and Esma Saada-Bouzid and Frédéric Rolland and Stéphanie Henry and Sylvie Rottey and Emmanuel Seront and Annemie Rutten and Athénais van der Elst and Konstantina Tsechilidou and Lieve Dirix and Catherine Fortpied and Ana Joaquim and Anne-Sophie Govaerts and Jean-Pascal Machiels},
  year = {2026},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2026.117791},
  url = {https://doi.org/10.1016/j.ejca.2026.117791}
}

RIS

TY  - JOUR
TI  - Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)
AU  - Rachel Galot
AU  - Christophe Le Tourneau
AU  - Lisa Licitra
AU  - Joël Guigay
AU  - Anthony Kong
AU  - Ingeborg Tinhofer
AU  - Caroline Even
AU  - Amaury Daste
AU  - Esma Saada-Bouzid
AU  - Frédéric Rolland
AU  - Stéphanie Henry
AU  - Sylvie Rottey
AU  - Emmanuel Seront
AU  - Annemie Rutten
AU  - Athénais van der Elst
AU  - Konstantina Tsechilidou
AU  - Lieve Dirix
AU  - Catherine Fortpied
AU  - Ana Joaquim
AU  - Anne-Sophie Govaerts
AU  - Jean-Pascal Machiels
PY  - 2026
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2026.117791
UR  - https://doi.org/10.1016/j.ejca.2026.117791
ER  -

APA

Galot, R., Tourneau, C. L., Licitra, L., Guigay, J., Kong, A., Tinhofer, I., Even, C., Daste, A., Saada-Bouzid, E., Rolland, F., Henry, S., Rottey, S., Seront, E., Rutten, A., Elst, A. V. D., Tsechilidou, K., Dirix, L., Fortpied, C., Joaquim, A., Govaerts, A., & Machiels, J. (2026). Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM). European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117791

Source records

crossref · retrieved 2026-11-05T10:23:25.102Z